SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000919574-20-001123
Filing Date
2020-02-13
Accepted
2020-02-13 17:16:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8472605.htm SC 13G/A 124126
  Complete submission text file 0000919574-20-001123.txt   125622
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87931 | Film No.: 20612034
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2460
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 202924429 | Fiscal Year End: 1231
Type: SC 13G/A